FDA To Decide If Pfizer Vaccine Should Roll Out Nationwide

A committee of scientists will hold a meeting Thursday to decide if the FDA should roll out the Pfizer vaccine nationwide.

They plan to look at all clinical and trial data collected, as some have seen allergic reactions to the vaccine so far.

Oklahoma City's Lynn Institute says the Pfizer vaccine is in the state right now.

Local health officials say some could see mild reaction, but this shouldn't scare people away from getting the vaccine..

Within the last 24 hours, the United Kingdom warned people with severe allergies to food or medications not to get the vaccine after two people had bad reactions.

Healthcare workers say both patients were okay after treatment.

The Lynn Institute held clinical trials for the vaccine here in the Oklahoma City metro.

Lynn Institute CEO, Carlos Blanco says Pfizer reported no issues related to allergic reactions in the first 40,000 patients of their trials.

"It is a shame there was doubt cast on this vaccine,” said Blanco. “What had been accomplished by the scientific community and these vaccine manufacturers is absolutely historic."

The Lynn Institute says once the FDA grants emergency use, It will immediately become available for local frontline workers.

They say the reward of taking the vaccine outweighs the risk.

Oklahoma is initially expecting over 30,000 doses of the Pfizer vaccine.

Officials say it should become available to the public in 2021.